Xeris Biopharma Holdings Cash Flow Statement (2020-2026)

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026	Jun2026
Operating Activities
Net Income (Quarter)	-26.01M	-50.79M	-33.71M	-26.18M	-21.83M	-12.93M	-16.83M	-19.84M	-12.19M	-13.39M	-18.98M	-15.01M	-15.74M	-5.11M	-9.22M	-1.93M	0.62M	11.08M	2.23M	-31.10M
Share-based Compensation (Quarter)	8.27M	2.74M	3.30M			12.16M	2.56M	20.04M		0.05M	3.77M	-0.28M	0.08M	0.17M	8.00M	1.45M	7.64M	-6.22M	17.02M	0.19M
Deferred Taxes (Quarter)			0.06M	-0.14M	-0.15M	-1.19M		-0.68M	0.68M	-1.25M	0.31M	0.75M	-3.32M
Gains from Investment Securities (Quarter)	-0.08M	0.79M
Cash from Operations (Quarter)	-22.61M	-28.95M	-48.41M	-20.61M	-17.75M	-16.12M	-26.14M	-13.74M	-14.61M	7.47M	-20.30M	-10.35M	-8.30M	1.98M	-10.03M	0.18M	18.43M	20.04M	9.87M	8.26M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)	-0.07M	-0.06M	-0.05M	-0.08M	-0.02M	-0.04M	0.38M	0.43M	0.30M	0.15M	0.18M	0.30M	0.19M	0.07M
Amortization of Deferred Charges (Quarter)	0.20M	0.23M	0.22M	0.50M	0.40M	0.49M	0.50M	0.60M	0.60M	0.50M	0.18M	0.80M	0.80M	0.81M	0.80M	0.80M	0.80M	-1.97M	0.90M	0.90M
Depreciation & Amortization (CF) (Quarter)	0.32M	0.35M	0.32M	0.35M	0.36M	0.37M	0.36M	0.39M	0.39M	0.35M	0.33M	0.28M	0.31M	0.31M	0.32M	0.33M	0.34M	0.34M	0.34M	0.32M
Change in Working Capital
Change in Receivables (Quarter)	1.27M	-0.45M	5.93M	2.37M	1.76M	3.31M	0.03M	-0.64M	15.74M	-6.77M	-1.78M	5.03M	-1.30M	-0.72M	5.92M	6.72M	0.70M	-2.70M	5.25M	1.81M
Change in Inventory (Quarter)	1.26M	2.27M	0.16M	0.15M	1.66M	5.50M	3.82M	7.43M	2.15M	1.40M	2.33M	2.27M	1.05M	3.14M	3.62M	7.57M	4.08M	4.01M	-0.85M	9.50M
Change in Account Payables (Quarter)	-0.90M	4.35M	2.17M	-4.46M	-2.71M	0.69M	6.93M	0.08M	0.30M	-0.35M	-4.47M	-1.59M	1.65M	-5.20M	4.06M	-4.43M	2.00M	-1.70M	4.25M	0.29M
Change in Accured Expenses (Quarter)	0.02M	-1.25M	-2.69M	1.61M	-11.06M	0.75M	0.10M	1.58M	-13.69M	15.40M	-1.12M	2.95M	0.47M	-3.37M	1.36M	-4.59M	4.62M	1.92M	-4.68M	1.67M
Investing Activities
Capital Expenditures (Quarter)		0.13M
Change in Acquisitions & Divestments (Quarter)	29.45M	10.50M	6.70M	12.10M	6.88M	9.30M		10.00M	15.00M	15.00M	5.00M	10.00M	15.00M	10.24M
Cash from Investing Activities (Quarter)	18.50M	36.60M	6.72M	11.87M	6.71M	9.17M	-43.98M	8.45M	14.65M	14.87M	-19.65M	4.60M	9.91M	10.02M	-0.01M	-0.28M	-0.07M	-0.33M	-0.33M	-0.21M
Financing Activities
Other financing activities (Quarter)	-0.21M	0.03M	0.01M	0.50M	-0.50M			0.55M		-0.52M	0.46M			-0.46M	4.86M	-4.03M	8.34M		0.85M	0.60M
Cash from Financing Activities (Quarter)	0.00M	0.12M	78.19M	0.31M	-0.19M	49.16M	-0.86M	0.56M	-0.07M	-1.23M	35.19M	0.66M	-0.08M	0.40M	-3.14M	0.94M	13.85M	-0.27M	-8.84M	1.94M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)			30.00M
Additional items
Exchange Rate Effect (Quarter)	-0.00M	-0.00M	-0.00M		0.00M
Change in Cash (Quarter)	-4.11M	7.78M	36.50M	-8.43M	-11.23M	42.20M	-70.98M	-4.74M	-0.03M	21.11M	-4.76M	-5.09M	1.53M	12.39M	-13.18M	0.84M	32.21M	19.44M	0.71M	10.00M
Free Cash Flow (Quarter)	-22.61M	-29.08M	-48.41M	-20.61M	-17.75M	-16.12M	-26.14M	-13.74M	-14.61M	7.47M	-20.30M	-10.35M	-8.30M	1.98M	-10.03M	0.18M	18.43M	20.04M	9.87M	8.26M
Net Cash Flow (Quarter)	-4.11M	7.78M	36.50M	-8.43M	-11.23M	42.20M	-70.98M	-4.74M	-0.03M	21.11M	-4.76M	-5.09M	1.53M	12.39M	-13.18M	0.84M	32.21M	19.44M	0.71M	10.00M

Research Tools

Datasets

Plans

Developers

Xeris Biopharma Holdings XERS Cash Flow Statement (2020-2026)

Research Tools

Datasets

Plans

Developers

Xeris Biopharma Holdings XERS Cash Flow Statement (2020-2026)

Create an account

Sign In

Reset Password